glp-1 receptor agonist mechanism GLP1 Agonists—Effects beyond Obesity and Diabetes The Impact of GLP-1 Receptor
Description
Why PatchAid
Get the details at ADW Diabetes.
GLP-1 agonists are regularly prescribed by doctors for patients with Type 2 Diabetes. And now theyre the next big thing in the weight loss world.
This analysis of survey data finds that over 40% of adults under 65 with private insurance could be indicated for a GLP-1 drug though relatively few have a claim, suggesting that a much smaller share seeks treatment through healthcare providers.
Deal Snapshot: Novo is partnering with Ascendis on less frequently dosed drugs for metabolic diseases, committing up to $285m for a lead program, a once-monthly GLP-1 receptor agonist.
